In terms of severity, the patients with moderate to severe NAFLD presented slightly higher ANGPTL8 levels than the patients with mild NAFLD; however, there was still no significant difference observed. Here, ANGPTL8 is linked to metabolic dysfunction-associated steatotic liver disease.